Manimaran D, Elangovan N, Palanisamy V. Anti-Tumorgenic Impact of Nano-Formulated Peptide HIF-Alpha Therapy by DMBA Induced Mammary Carcinoma in Rodent Type. Jordan j. pharm. sci. [Internet]. 2024 Dec. 20 [cited 2025 Dec. 3];17(4):783-9. Available from: https://jjournals.ju.edu.jo/index.php/jjps/article/view/2482